Key Details
Price
$0.66Annual EPS
-$47.88Annual ROE
-438.40%Beta
-0.05Events Calendar
Next earnings date:
May 14, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 31, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Dec 18, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Entero Therapeutics, Inc. (NASDAQ: ENTO ), relating to the proposed merger with Journey Therapeutics, Inc. Under the terms of the agreement, the shareholders of Journey will acquire 99% of the equity of Entero.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Entero Therapeutics, Inc. (NASDAQ: ENTO) and Journey Therapeutics, Inc. is fair to Entero shareholders. Upon closing of the proposed transaction, Journey shareholders will acquire 99% of the equity of Entero. Halper Sadeh encourages Entero shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh.
New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy
FAQ
- What is the primary business of Entero Therapeutics?
- What is the ticker symbol for Entero Therapeutics?
- Does Entero Therapeutics pay dividends?
- What sector is Entero Therapeutics in?
- What industry is Entero Therapeutics in?
- What country is Entero Therapeutics based in?
- When did Entero Therapeutics go public?
- Is Entero Therapeutics in the S&P 500?
- Is Entero Therapeutics in the NASDAQ 100?
- Is Entero Therapeutics in the Dow Jones?
- When was Entero Therapeutics's last earnings report?
- When does Entero Therapeutics report earnings?
- Should I buy Entero Therapeutics stock now?